Neoplasia/BPH

	Exploring the feasibility of inferring prostate cancer pathological grade from multiparametric MRI text reports using natural language processing: assessment of four large language models. Abdom Radiol (NY) Niu Y, Shen L, Liu J, Yang Z, Wang L, Cheng Y. PMID: 41945149 [PubMed - as supplied by publisher]
	Advances in Androgen Deprivation Therapy-Sparing Strategies: Ongoing Studies in Metastatic Castration-Sensitive Prostate Cancer. Clin Genitourin Cancer Morgans AK, Sentana-Lledo D, Wildgust M, Santos AD. PMID: 41945087 [PubMed - as supplied by publisher]
	Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial. Eur Urol Economides MP, O'Donnell PH, Alva AS, Milowsky MI, Kollmeier M, Niglio S, Persily J, Sweis RF, Rose T, Iyer G, Spratt D, Palmbos P, Hochman T, Goldberg JD, Francese K, Griglun S, Leis D, Steinberg GD, Wysock J, Schiff PB, Sanfilippo NJ, Taneja SS, Wise DR, Huang WC, Balar AV. PMID: 41945031 [PubMed - as supplied by publisher]
	Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database. Int J Urol Hatakeyama S, Yamamoto K, Yamamoto H, Yasui T, Kamoto T, Ito A, Kikuchi E, Kume H. PMID: 41944584 [PubMed - indexed for MEDLINE]
	The molecular pathology of prostate cancer: an update for practising pathologists. Histopathology Caramella Pereira F, De Marzo AM. PMID: 41943889 [PubMed - as supplied by publisher]
	Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment? Med Res Rev Fonseca LRS, Feijó M, Vaz CV, Pereira BJ, Laurentino S, Palmeira-de-Oliveira A, Socorro S. PMID: 41943884 [PubMed - as supplied by publisher]
	Metabolic-Immune Coupling in Urologic Cancers: Macrophage Reprogramming as a Therapeutic Nexus. Int J Biol Sci Huang W, Li W, Shangguan W, Yang L, Li Z, Sun B, Ma C, Yang X, Peng P, Zhao J, Cheng B, Wu P. PMID: 41943838 [PubMed - indexed for MEDLINE]
	Oncological Safety of Testosterone Replacement Therapy in Men With a History of Prostate Cancer: A Systematic Review. Cureus Alexandre Alves VA, Brasileiro Silva AA, Falcao Bisneto EL, Macedo HF, Lima GS, Santos De Souza LGP, Barbosa PEA, Medeiros Júnior PF. PMID: 41943753 [PubMed]
	Risk Factors and Predictive Model for Peripherally Inserted Central Catheter Tip Migration in Patients With Bladder Cancer. Arch Esp Urol Zheng K, Cui X, Liu Y, Du M, Yang G. PMID: 41943705 [PubMed - indexed for MEDLINE]
	Clinical and Pathological Features of Renal Cell Carcinoma in Young Adults. Arch Esp Urol Öztürk A, Kaya . PMID: 41943694 [PubMed - indexed for MEDLINE]
	Distribution of PD-1.5 Gene Variant (rs2227981): A Possible Approach for Risk Assessment in Bladder Cancer. Arch Esp Urol Kayar K, Verim L, Sonmez D, Kadihasanoglu M, Demirkol S, Kucukhuseyin O, Hakan MT, Lamami Y, Kiran B, Yaylim I. PMID: 41943691 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Keyhole Limpet Hemocyanin in Bacillus Calmette-GuÃ©rin Unresponsive Non-muscle Invasive Bladder Cancer. Arch Esp Urol Chernobilsky V, Gonzalez IT, Favre G. PMID: 41943689 [PubMed - indexed for MEDLINE]
	Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations. Arch Esp Urol Li H, Zhang F, Liu X, Wang L. PMID: 41943686 [PubMed - indexed for MEDLINE]
	Multi-Omics Integration in Urological Cancers: Unlocking Precision Diagnosis and Therapy Through Big Data. Arch Esp Urol Delrue C, Speeckaert MM. PMID: 41943684 [PubMed - indexed for MEDLINE]
	Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges. Arch Esp Urol Valencia Nieto P, López-Campos F, Diezhandino García P, Duque-Santana V, Gómez-Aparicio MA, Ocanto A, González de Dueñas M, Maldonado Pijoan X, Shelan M, Álvarez-Maestro M, Couñago F. PMID: 41943683 [PubMed - indexed for MEDLINE]
	Primitive Neuroectodermal Kidney Tumor in Adults. A Systematic Review. Arch Esp Urol Cabello-Gómez E, Rivero-Belenchón I, Congregado-Ruiz CB, Osmán-García I, Medina-López RA. PMID: 41943682 [PubMed - indexed for MEDLINE]
	Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence. Technol Cancer Res Treat He JX, Li L, Chen S, Chen RJ, Zhuang JL, Liu C, Burrow W, Chang J, Tanziela T, Bonfil RD, Wong NK, Tao W. PMID: 41943522 [PubMed - indexed for MEDLINE]
	Developing a web-based dashboard for adaptive radiotherapy workflows. J Appl Clin Med Phys DiTusa C, Alexandrian A, Mavroidis P, Sargent E, Allen M, Schneider CW, Stathakis S. PMID: 41942797 [PubMed - indexed for MEDLINE]
	The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients. EMBO Mol Med Bilusic M, Gannamedi DP, Challu B, Ferdous S, Mateo-Victoriano B, Pokharel S, Bayik D, Sharma J, Lombard DB, Rai P. PMID: 41942753 [PubMed - as supplied by publisher]
	Efferocytosis-related gene PLG in prognosis, immune correlation, and contribution to malignant behavior in vitro and in vivo of clear cell renal cell carcinoma. Sci Rep Zhou Y, Zhang Z, Liu Y, Liu W, Dai J. PMID: 41942551 [PubMed - as supplied by publisher]

Articles 1 - 20 / 186860

Page 1 of 9343



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy